Manage Your Workingnegative Thoughts Through Hypnosis (Hypnosis)

February 13, 2026 updated by: Annalisa Boscolo, University of Padova

Manage Your Negative Thoughts: Stress, Anxiety Management Through Hypnosis in Medical Trainees

Medical doctor generally are exposed to several risks and pressures, it is not a case that several meta-analyses have shown high stress and anxiety level in these workers. Stress management represents a very important topic. Being a doctor means dealing with continous effort and arousal management to provide the best treatment through executive functions capacity. This is particularly true for younger medical trainees; that have also to learn how to deal with failure and the curve of learning. Hypnosis has been shown to be very effective at modulating executive functions and sympathovagal balance, with large effect in post traumatic stress disease (PTSD), anxiety and executive function modulation. Therefore, this study aim to investigate if hypnosis could be beneficial among medical trainees for managing negative thoughts related to work.

Study Overview

Detailed Description

Stress and anxiety are very important issues in medical training. Several methods have been applied, from psychotherapy to biofeedback, but the physiological component usually have been dismissed. Training medical trainees to manage their physiological activity through hypnosis can probably transfer practical results, i.e. increased wellbeing, modulation of the working energy and the transfer from planning to properly execution. To obtain this results after a basal evaluation of physiological data (HR; Heart rate, HRV, Heart Rate Variability, EDA; Electrodermal activity, and SCr; Skin conductance responses) stress and of anxiety levels, , with PSS-10 scale, VAS stress, VAS anxiety and Tower of London test ( TOL-R), participants will recollect a negative memory for 3 minutes to monitor their response. After that a brief session of hypnosis will be performed with positive memories being recollected while all physiological data will be monitored. Then participants will be subjected again to the negative memory task end at the end of the session the same test of the basal evaluation will be carried out.

Study Type

Interventional

Enrollment (Actual)

26

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Italy
      • Padua, Italy, Italy, 35126
        • Istituto di Anestesia e Rianimazione
    • PD
      • Padua, PD, Italy, 35126
        • University of Padova

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • age > 18 years old,
  • being medical doctor or at first year of residency in Anesthesiology
  • obtained written informed consent

Exclusion Criteria:

  • Neurological issues affecting stress responses
  • Diabetes
  • Cardiovascular conditions (i.e., hypertension, orthostatic hypotension etc)
  • Being under psychiatric medications
  • Psychological or psychiatric diseases

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Non-Randomized
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Hypnosis and negative memory (n. 26)
T0) basal evaluation of physiological data T1) evaluation of physiological data after recollecting a negative memory for 3 minutes T2) evaluation of physiological data after that a brief session of hypnosis (performed with positive memories) T3) evaluation of physiological data recolling, for the second time, the negative memory.
Arm Description: T0) basal evaluation of physiological data T1) evaluation of physiological data after recollecting a negative memory for 3 minutes T2) evaluation of physiological data after that a brief session of hypnosis (performed with positive memories) T3) evaluation of physiological data recolling, for the second time, the negative memory.
Sham Comparator: Control group (n. 23)
Active control group con breath-focused attention. Allocation: Non-randomized
Arm Description: Active control group con breath-focused attention. Allocation: Non-randomized

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Evaluation of the variations of the tonic and phasic component of the Electrodermal Activity (EDA,microSiemens) and Skin conductance response comparing pre and post-hypnosis (SCr/min)
Time Frame: T0) Within 3 minutes from electrodes application (at baseline), T1) within 3minute after a negative memory (w/o hypnosis), T2) within 3minutes after a positive memory, T3) within 3minutes after recalling the negative memory (after hypnosis application)
Evaluation of the variations of the tonic and phasic component of the Electrodermal Activity (EDA,microSiemens) and Skin conductance response comparing pre and post-hypnosis (SCr/min)
T0) Within 3 minutes from electrodes application (at baseline), T1) within 3minute after a negative memory (w/o hypnosis), T2) within 3minutes after a positive memory, T3) within 3minutes after recalling the negative memory (after hypnosis application)
Evaluation of the executive performance comparing pre- and post-hypnosis through Tower of London-Revised (TOL-R) (number of correct responses)
Time Frame: Within 3 minutes from the first negative memory (without hypnosis) and then, within 3 minutes from the negative memory (with hypnosis)
Evaluation of the executive performance comparing pre- and post-hypnosis through Tower of London-Revised (TOL-R) (number of correct responses)
Within 3 minutes from the first negative memory (without hypnosis) and then, within 3 minutes from the negative memory (with hypnosis)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Evaluation of the variations of psychological stress response to a negative memory related to work between pre and post hypnosis on a scale from 0 to 10
Time Frame: Within 3 minutes from the first negative memory (without hypnosis) and then, within 3 minutes from the negative memory (with hypnosis)
Evaluation of the variations of psychological stress response to a negative memory related to work between pre and post hypnosis on a scale from 0 to 10
Within 3 minutes from the first negative memory (without hypnosis) and then, within 3 minutes from the negative memory (with hypnosis)
Evaluation of the Heart rate variability (HRV) comparing pre and post-hypnosis (ms)
Time Frame: T0) Within 3 minutes from electrodes application (at baseline), T1) within 3minute after a negative memory (w/o hypnosis), T2) within 3minutes after a positive memory, T3) within 3minutes after recalling the negative memory (after hypnosis application)
Evaluation of the Heart rate variability (HRV) comparing pre and post-hypnosis (ms)
T0) Within 3 minutes from electrodes application (at baseline), T1) within 3minute after a negative memory (w/o hypnosis), T2) within 3minutes after a positive memory, T3) within 3minutes after recalling the negative memory (after hypnosis application)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 6, 2025

Primary Completion (Actual)

April 1, 2025

Study Completion (Actual)

April 1, 2025

Study Registration Dates

First Submitted

December 29, 2024

First Submitted That Met QC Criteria

January 10, 2025

First Posted (Actual)

January 16, 2025

Study Record Updates

Last Update Posted (Actual)

February 18, 2026

Last Update Submitted That Met QC Criteria

February 13, 2026

Last Verified

February 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stress

Clinical Trials on Experimental: Hypnosis and negative memory

Subscribe